45
Growth Score
pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1736531
Aeon Respire develops inhaled therapies for respiratory diseases, focusing on drug discovery and development.
- John Sullivan: Founder, CEO, CSO and CTOPast Role: PolestarBio, Founder and Principal
- Dirk Smith: Founder, Vice President and R and D
About the Company
Aeon Respire develops inhaled therapies aimed at treating respiratory diseases. The company focuses on addressing inflammatory and obstructive airway conditions by targeting structural lung cells involved in airway narrowing. Its research emphasizes novel biological targets expressed in both smooth muscle and airway epithelium, with the goal of
improving long-term respiratory health.
